Epithelial TGFβ engages growth-factor signalling to circumvent apoptosis and drive intestinal tumourigenesis with aggressive features
- Flanagan, Dustin J.
- Amirkhah, Raheleh
- Vincent, David F.
- Gundaz, Nuray
- Gentaz, Pauline
- Cammareri, Patrizia
- McCooey, Aoife J.
- McCorry, Amy M. B.
- Fisher, Natalie C.
- Davis, Hayley L.
- Ridgway, Rachel A.
- Lohuis, Jeroen
- Leach, Joshua D.G.
- Jackstadt, Rene
- Gilroy, Kathryn
- Mariella, Elisa
- Nixon, Colin
- Clark, William
- Hedley, Ann
- Markert, Elke K.
- Strathdee, Douglas
- Bartholin, Laurent
- Redmond, Keara L.
- Kerr, Emma M.
- Longley, Daniel B.
- Ginty, Fiona
- Cho, Sanghee
- Coleman, Helen G.
- Loughrey, Maurice B.
- Bardelli, Alberto
- Maughan, Timothy S.
- Campbell, Andrew D.
- Lawler, Mark
- Leedham, Simon J.
- Barry, Simon T.
- Inman, Gareth J.
- van Rheenen, Jacco
- Dunne, Philip D.
- Sansom, Owen J.
DOIAbstract
The pro-tumourigenic role of epithelial TGFβ signalling in colorectal cancer (CRC) is controversial. Here, we identify a cohort of born to be bad early-stage (T1) colorectal tumours, with aggressive features and a propensity to disseminate early, that are characterised by high epithelial cell-intrinsic TGFβ signalling. In the presence of concurrent Apc and Kras mutations, activation of epithelial TGFβ signalling rampantly accelerates tumourigenesis and share transcriptional signatures with those of the born to be bad T1 human tumours and predicts recurrence in stage II CRC. Mechanistically, epithelial TGFβ signalling induces a growth-promoting EGFR-signalling module that synergises with mutant APC and KRAS to drive MAPK signalling that re-s...
Add to ORKG